MoneyWorks4Me

Krebs Biochemicals & Industries informs about appointment of CFO

14 Sep 2018 Evaluate

In continuation to the outcome of the board meeting regarding appointment of S. Phani Srinath as Chief Financial Officer (CFO) of the company based on the recommendations of the Audit and Nomination and Remuneration Committees, vide the letter dated 10th September 2018, Krebs Biochemicals & Industries has informed about a brief profile of S. Phani Srinath as required under the Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1854.95
Dr. Reddys Labs. 1204.50
Cipla 1405.20
Lupin 2099.00
Zydus Lifesciences 1175.95
View more..